Skip to content

Association between heart failure pharmacotherapy and nutritional status

Association between heart failure pharmacotherapy and nutritional status in patients with heart failure - Association between heart failure pharmacotherapy and nutritional status

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000058393
Enrollment
300000
Registered
2025-07-07
Start date
2025-12-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure (HF)

Interventions

None listed

Sponsors

Nippon Boehringer Ingelheim Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients aged >= 18 years who are diagnosed with HF during hospitalization within the Study Period (2) Patients discharged on or after Index Date. (3) Patients with CONUT, GNRI, or PNI data during the Baseline Period and after Baseline Period. (4) Patients who have medical records in the Medical Data Vision Co., Ltd. (MDV) database for one year or more before the Index Date.

Exclusion criteria

Exclusion criteria: (1) Patients who have ICD-10 codes identifying HF before Index Date. (2) Patients who underwent cardiac pacemaker, implantable cardioverter-defibrillator implantation, cardiac resynchronization therapy, catheter ablation, coronary artery bypass graft surgery, percutaneous coronary intervention, surgical or percutaneous intervention for heart valve disease in Look Back Period. (3) Patients who were hospitalized for acute myocardial infarction in Look Back Period.

Design outcomes

Primary

MeasureTime frame
Time to the first worsening of nutritional status (Controlling Nutritional Status score [CONUT score]/Geriatric Nutritional Risk Index [GNRI], Prognostic Nutritional Index [PNI]) from baseline.

Countries

Japan

Contacts

Public ContactDaiki Asano

Nippon Boehringer Ingelheim Co., Ltd. Medicine Dept. 1 Clinical Development Medical Affairs Cardio Renal Metabolism, Medicine Division

daiki.asano@boehringer-ingelheim.com070-3979-1845

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026